跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lintaz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lintaz
Approved
STANDARD
Lintaz
Kilitch Drugs (India) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6f6fde4385b6e419
Company
Kilitch Drugs (India) Ltd.
Type
Standard
Approval Details
Approval Id
6f6fde4385b6e419
Drug Approval Philippines Name
Lintaz
Product Name
Lintaz
Registration Number
DRP-10697-01
Brand Name
Lintaz
Generic Name
Piperacillin (as sodium) + Tazobactam (as sodium)
Dosage Form
Powder for Injection for IV Infusion
Dosage Strength
4 g/ 500 mg
Manufacturer
Kilitch Drugs (India) Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
ECE Pharmaceutical, Inc
Issuance Date
24 October 2022
Expiry Date
10 November 2026
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6f6fde4385b6e419
Type
Standard
Back to Philippines FDA Approvals